People's Justice

Indiana · Claims for harm linked to Dupixent

Claims for harm linked to Dupixent in Indiana

See If You Qualify

Free · No obligation · About 2 minutes

Filing deadline2 years from discovery of injury (10-year repose)Ind. Code § 34-11-2-4

Deadlines vary with the facts of each case. A lawyer can confirm yours.

Updated

01 · Your filing deadline

What is the deadline in Indiana?

Indiana: 2 years for product liability (Ind. Code § 34-11-2-4). Discovery rule applies — the limitations period begins when the plaintiff knew or should have known of the injury. Indiana also imposes a 10-year product liability statute of repose (Ind. Code § 34-20-3-1). A lawyer can confirm yours.

2 years from discovery of injury (10-year repose)

Source: Ind. Code § 34-11-2-4

Deadlines vary; a lawyer can confirm yours. An older diagnosis or a past filing window does not, by itself, establish whether you have a claim.

Woman on the phone on her sofa, smiling
A lawyer can check which filing rules apply to your circumstances.

02 · Where cases are heard

Where would my case be heard?

Indiana's large population of 6.8 million and extensive healthcare infrastructure drive substantial Dupixent prescribing, with an estimated 52,000 patients since 2017. Indianapolis serves as the pharmaceutical hub, with Indiana University Health, IU Simon Comprehensive Cancer Center, and a large community of specialty dermatologists and allergists. Eli Lilly's headquarters in Indianapolis have made the state a pharmaceutical industry center, though Lilly's presence does not directly benefit Sanofi or Regeneron in litigation. Indiana's Product Liability Act (Ind. Code § 34-20-1-1 et seq.) governs product liability claims, and its 10-year statute of repose runs from delivery of the product to the initial user or consumer; a claim that accrues 8 to 10 years after delivery may still be brought within 2 years after it accrues (Ind. Code § 34-20-3-1(b)).

Indiana has two federal judicial districts: the Northern District (Hammond/Fort Wayne/South Bend) and Southern District (Indianapolis/Evansville). The Southern District handles most pharmaceutical litigation filed in Indianapolis. Indiana follows a modified comparative fault system (51 percent bar) and has a Product Liability Act that governs claims against drug manufacturers.

How this works nationally

For the overall process and updates, read the Claims for harm linked to Dupixent overview. This page covers the local information available for Indiana.

What happens when I check?

You answer a few short questions about what happened. If you send them, your answers are kept on file. If a participating law firm takes these cases, it may contact you. People's Justice is not a law firm.

Live in Indiana? Read what applies in your state.

Register your interest. If a participating law firm takes these cases, it may contact you.

Register your interest

Sources

  1. Ind. Code § 34-11-2-4